Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease
Autor: | Paul E. Epstein, Jeffrey A. Kern, Thomas N. Markham, Mark R. Cullen, Ronald P. Daniele, Milton D. Rossman, Otto P. Preuss, Jack A. Elias |
---|---|
Rok vydání: | 1988 |
Předmět: |
Pathology
medicine.medical_specialty Sarcoidosis Berylliosis Occupational disease In Vitro Techniques Sensitivity and Specificity Biopsy Internal Medicine medicine Humans Lymphocytes Prospective Studies Lung medicine.diagnostic_test business.industry Respiratory disease General Medicine medicine.disease respiratory tract diseases Respiratory Function Tests medicine.anatomical_structure Bronchoalveolar lavage Chronic Disease Beryllium business Bronchoalveolar Lavage Fluid Cell Division Beryllium Disease |
Zdroj: | Annals of internal medicine. 108(5) |
ISSN: | 0003-4819 |
Popis: | STUDY OBJECTIVE to ascertain whether measuring the proliferative response of bronchoalveolar lymphocytes to beryllium salts is useful for diagnosing chronic beryllium disease. DESIGN prospective case series compared to normal volunteers and patients with sarcoidosis. SETTING university referral center. PATIENTS twenty-three consecutive beryllium workers were evaluated. Fourteen had chronic beryllium disease diagnosed on the basis of histologic evidence of a progressive pulmonary granulomatosis. Four had biopsy evidence of non-beryllium disease. Three had probable chronic beryllium disease but did not have lung biopsies. Two did not have biopsies and had basilar fibrosis on chest roentgenogram suggestive of non-beryllium lung disease. These patients were compared with 6 normal volunteers and 16 patients with sarcoidosis. MEASUREMENTS AND MAIN RESULTS bronchoalveolar lavage was done and the proliferative response of the lung cells to two beryllium salts was tested. A positive proliferative test was defined as a stimulation index of more than five on two determinations. The sensitivity of this test was 100% in the 14 patients with definite chronic beryllium disease. The specificity of the test was also 100% among the normal volunteers and the 16 patients with sarcoidosis. The test was positive in none of the four patients with biopsy evidence of non-beryllium disease, none out of two patients with lower lobe fibrosis suggestive of non-beryllium disease, and all of three patients with probable chronic beryllium lung disease. CONCLUSIONS the proliferative response of bronchoalveolar lymphocytes to beryllium appears to be a useful test for chronic beryllium disease. |
Databáze: | OpenAIRE |
Externí odkaz: |